J&J Medical Connect
Immunology
Immunology

Congress Materials – Advances in Inflammatory Bowel Diseases (AIBD 2026)

 

2026 Advances in Inflammatory Bowel Disease | Dec 7-9 | Orlando, Florida

This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.

Efficacy of Guselkumab for the Treatment of Moderately to Severely Active Crohn’s Disease by Involved Crohn’s Disease Location: Results from the Phase 3 GRAVITI Study

D’Haens, Bishu, Morrison, Van Rampelbergh, Van Duijnhoven, Chakravarty, DeYulia, Hart


This document will be available on Dec 7th 2026

Guselkumab in Perianal Fistulizing Crohn’s Disease: Week 48 Results from the Phase 3, Randomized, Double-Blind, Placebo-Controlled FUZION Trial

Hart, Dignass, Jairath, Hisamatsu, Sands, Spinelli, Connor, D’Hoore, Reinisch, Danese, Schwartz, Panés, Verstockt, Stift, Nazar, Van Denderen, Sakamoto, Masuda, Xu, Bravatà, D’Haens, Peyrin-Biroulet


This document will be available on Dec 7th 2026

Safety of Approved Guselkumab Regimens in Inflammatory Bowel Disease Through 2 Years: Integrated Safety Analysis of Clinical Studies in Crohn’s Disease and Ulcerative Colitis

Sands, Orleck, Li, Corbett, DeYulia, Chakravarty, Sebastian


This document will be available on Dec 7th 2026

Treatment Gaps, Surgical Burden, and Healthcare Resource Utilization Around the Time of Diagnosis in Fistulizing Crohn's Disease: A US Claims Analysis

Chang, Kachroo, Seminerio-Diehl


This document will be available on Dec 7th 2026

 

Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.

Would you like to clear and leave your conversation? Message history will be lost.